In line with the ground-breaking pay-per-use philosophy, Mind the Byte has launched six new programs for computational drug design on their SaaS platform (Software as a Service), which the company has been marketing since 2011. The new software expands the services currently on offer and helps cut drug-development time and costs up to 30% for companies and researchers. The products were launched at prices that adapt to the needs of each user.

The new SaaS programs, designed exclusively by the Mind the Byte team of engineers, bioinformatics and computational chemists at the Barcelona Science Park (PCB), offer the following applications:

Chaac: 2D ligand-based virtual screening

Kizin: 2D ligand-based compound selection

Ik: 3D virtual screening

Ixtab: management of chemical libraries

Kin: blind-docking technology for predicting protein-ligand interactions

Itzamma: identify active compounds for a target using docking tech

The new products were officially presented at the BIO-Europe Spring congress in Stockholm this past April and now the aim is to continue promoting the SaaS in mature pharmaceutical and biotechnology markets like the United States, Denmark, Germany and Japan, in addition to Spain. Just a few days ago, in fact, the Bioga cluster invited Mind the Byte CEO Alfons Nonell-Canals to explain to a group of Galician biotechnicians how they could benefit from bioinformatics, not only in the health arena but also in agrifood, which is an important part of the economy in Galicia.

"When we created the SaaS platform, we had a clear aim: to break through the most important technological and economic barriers of computational design and help reduce time-to-market for new drugs, thus speeding up the arrival of innovative treatments for unmet medical needs," says Nonell-Canals.

To achieve it, Mind the Byte is applying mathematical models and algorithms using machine learning (artificial intelligence) and big data.

In addition to the SaaS platform, Mind the Byte also offers personalised computational drug-discovery services for biotech and pharmaceutical companies and research centres around the world.

Since 2013, Mind the Byte has been a technology partner of Amazon Web Services (AWS) and a member of the Microsoft BizSpark Plus programme.

Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un estudio de INCLIVA muestra el efecto ...

by INCLIVA

Han desarrollado un estudio para evaluar la correlación entre el teji...

Photos Stream